T. Le Clerc acquisition
This article was originally published in The Rose Sheet
Executive SummaryBelgian healthcare company Omega Pharma has acquired Parisian cosmetics manufacturerT. LeClerc, company announces. Addition of T. LeClerc expands Omega Pharma's beauty portfolio to include prestige cosmetics and powders with sales of €7 mil., firm adds. T. LeClerc offers potential for international expansion, Omega Pharma adds. Established in 1881 by French pharmacist Théophile LeClerc, T. LeClerc products are sold in the U.S. through department and specialty stores. Acquisition follows Omega Pharma's purchase of Biodermal and Galenco dermo cosmetic skin care brands from Koninklijke Numico earlier this month...
You may also be interested in...
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.